05/08/2024
4:14 PM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form DEL AM | |
05/01/2024
3:37 PM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024
7:36 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2024
6:00 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/13/2024
7:52 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/13/2024
6:10 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/23/2024
7:12 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024
8:54 AM | Lombard Odier Asset Management Corp (0001491719) (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
7:55 AM | Deep Track Capital, LP (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
| Form SC 13G/A | |
02/12/2024
5:15 PM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
4:05 PM | Artal International S.C.A. (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
| Form SC 13G/A | |
12/01/2023
6:00 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/01/2023
6:00 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/01/2023
3:12 PM | Artal International S.C.A. (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
| Form SC 13G | |
08/16/2023
6:00 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2023
3:31 PM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/11/2023
6:00 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/03/2023
6:30 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
